Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker ARQT
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Masaru Matsuda Officer | ARQT Arcutis Biotherapeutics, Inc. | 40,000 | $1.4M | 10b5-1 | Nov 4, 2026 | Form 4 ↗ same day · 41,219 shares | Form 144 ↗ |
| Nov 2, 2026 | Todd Franklin Watanabe Officer | ARQT Arcutis Biotherapeutics, Inc. | 4,377 | $139.5K | — | Nov 2, 2026 | Form 4 ↗ 2 days later · 4,377 shares | Form 144 ↗ |
| Nov 2, 2026 | Masaru Matsuda Officer | ARQT Arcutis Biotherapeutics, Inc. | 1,219 | $38.8K | — | Nov 2, 2026 | Form 4 ↗ 2 days later · 41,219 shares | Form 144 ↗ |
| Nov 2, 2026 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 943 | $30.0K | — | Nov 2, 2026 | Form 4 ↗ 2 days later · 943 shares | Form 144 ↗ |
| Oct 20, 2026 | Larry Todd Edwards Former Officer | ARQT Arcutis Biotherapeutics, Inc. | 60,376 | $2.0M | — | Oct 20, 2026 | — | Form 144 ↗ |
| Oct 15, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 4,728 | $127.3K | 10b5-1 | Oct 15, 2026 | Form 4 ↗ 4 days later · 4,728 shares | Form 144 ↗ |
| Sep 16, 2026 | Larry Todd Edwards Former Officer | ARQT Arcutis Biotherapeutics, Inc. | 341,980 | $8.5M | — | Sep 16, 2026 | — | Form 144 ↗ |
| Sep 15, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 4,730 | $114.4K | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 2 days later · 4,730 shares | Form 144 ↗ |
| Sep 8, 2026 | Masaru Matsuda Officer | ARQT Arcutis Biotherapeutics, Inc. | 13,663 | $341.9K | 10b5-1 | Sep 8, 2026 | Form 4 ↗ 2 days later · 9,989 shares | Form 144 ↗ |
| Aug 27, 2026 | Terrie Curran Director | ARQT Arcutis Biotherapeutics, Inc. | 38,200 | $956.1K | — | Aug 27, 2026 | Form 4 ↗ 1 day later · 38,200 shares | Form 144 ↗ |
| Aug 20, 2026 | Terrie Curran Director | ARQT Arcutis Biotherapeutics, Inc. | 1,072 | $27.9K | — | Aug 20, 2026 | Form 4 ↗ 4 days later · 1,072 shares | Form 144 ↗ |
| Aug 19, 2026 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 1,697 | $45.8K | — | Aug 19, 2026 | Form 4 ↗ 2 days later · 1,697 shares | Form 144 ↗ |
| Aug 17, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 4,730 | $123.8K | 10b5-1 | Aug 17, 2026 | Form 4 ↗ 2 days later · 4,730 shares | Form 144 ↗ |
| Aug 11, 2026 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 15,000 | $397.8K | — | Aug 11, 2026 | Form 4 ↗ 2 days later · 15,000 shares | Form 144 ↗ |
| Aug 3, 2026 | Matsuda Masaru Officer | ARQT Arcutis Biotherapeutics, Inc. | 1,230 | $32.1K | — | Aug 3, 2026 | Form 4 ↗ 2 days later · 1,230 shares | Form 144 ↗ |
| Aug 3, 2026 | Todd Frank Watanabe Officer | ARQT Arcutis Biotherapeutics, Inc. | 4,375 | $114.3K | — | Aug 3, 2026 | Form 4 ↗ 2 days later · 4,375 shares | Form 144 ↗ |
| Aug 3, 2026 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 955 | $24.9K | — | Aug 3, 2026 | Form 4 ↗ 2 days later · 955 shares | Form 144 ↗ |
| Jul 15, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 4,730 | $127.3K | 10b5-1 | Jul 15, 2026 | Form 4 ↗ 2 days later · 4,730 shares | Form 144 ↗ |
| Jun 17, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 635 | $16.3K | 10b5-1 | Jun 17, 2026 | Form 4 ↗ same day · 4,731 shares | Form 144 ↗ |
| Jun 15, 2026 | Sue-Jean Lin Officer | ARQT Arcutis Biotherapeutics, Inc. | 4,946 | $120.6K | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 2 days later · 4,946 shares | Form 144 ↗ |
| Jun 15, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 4,096 | $100.0K | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 2 days later · 4,731 shares | Form 144 ↗ |
| May 11, 2026 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 222 | $4,673 | — | May 11, 2026 | Form 4 ↗ 2 days later · 222 shares | Form 144 ↗ |
| May 11, 2026 | Latha Vairavan officer | ARQT Arcutis Biotherapeutics, Inc. | 435 | $9,157 | — | May 11, 2026 | Form 4 ↗ 2 days later · 435 shares | Form 144 ↗ |
| May 4, 2026 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 684 | $16.1K | — | May 4, 2026 | Form 4 ↗ 2 days later · 684 shares | Form 144 ↗ |
| May 4, 2026 | Latha Vairavan Officer | ARQT Arcutis Biotherapeutics, Inc. | 1,341 | $31.7K | — | May 4, 2026 | Form 4 ↗ 2 days later · 1,341 shares | Form 144 ↗ |
| May 4, 2026 | Todd Watanabe Officer | ARQT Arcutis Biotherapeutics, Inc. | 3,172 | $74.9K | — | May 4, 2026 | Form 4 ↗ 2 days later · 3,172 shares | Form 144 ↗ |
| May 4, 2026 | Masaru Matsuda officer | ARQT Arcutis Biotherapeutics, Inc. | 8,256 | $192.4K | 10b5-1 | May 4, 2026 | Form 4 ↗ 2 days later · 8,256 shares | Form 144 ↗ |
| May 1, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 7,144 | $164.2K | 10b5-1 | May 1, 2026 | Form 4 ↗ 4 days later · 7,144 shares | Form 144 ↗ |
| Apr 1, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 10,000 | $238.8K | 10b5-1 | Apr 1, 2026 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Mar 2, 2026 | Masaru Matsuda officer | ARQT Arcutis Biotherapeutics, Inc. | 12,058 | $313.9K | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 1 day later · 12,058 shares | Form 144 ↗ |
| Mar 2, 2026 | Larry Todd Edwards Officer | ARQT Arcutis Biotherapeutics, Inc. | 3,687 | $92.8K | — | Mar 2, 2026 | Form 4 ↗ 1 day later · 3,687 shares | Form 144 ↗ |
| Mar 2, 2026 | Todd Watanabe Officer | ARQT Arcutis Biotherapeutics, Inc. | 37,349 | $940.5K | — | Mar 2, 2026 | Form 4 ↗ 1 day later · 37,349 shares | Form 144 ↗ |
| Mar 2, 2026 | Latha Vairavan officer | ARQT Arcutis Biotherapeutics, Inc. | 2,853 | $71.8K | — | Mar 2, 2026 | Form 4 ↗ 1 day later · 2,853 shares | Form 144 ↗ |
| Mar 2, 2026 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 6,287 | $158.3K | — | Mar 2, 2026 | Form 4 ↗ 1 day later · 6,287 shares | Form 144 ↗ |
| Mar 2, 2026 | Keith Leonard Board of Director | ARQT Arcutis Biotherapeutics, Inc. | 39,272 | $997.2K | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 2 days later · 39,272 shares | Form 144 ↗ |
| Mar 2, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 10,000 | $256.5K | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Feb 4, 2026 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 9,794 | $252.7K | 10b5-1 | Feb 4, 2026 | Form 4 ↗ same day · 13,469 shares | Form 144 ↗ |
| Feb 2, 2026 | Masaru Matsuda officer | ARQT Arcutis Biotherapeutics, Inc. | 40,638 | $1.0M | 10b5-1 | Feb 2, 2026 | Form 4 ↗ 2 days later · 40,638 shares | Form 144 ↗ |
| Feb 2, 2026 | Todd Edwards Officer | ARQT Arcutis Biotherapeutics, Inc. | 2,052 | $52.3K | — | Feb 2, 2026 | Form 4 ↗ 2 days later · 2,052 shares | Form 144 ↗ |
| Feb 2, 2026 | Latha Vairavan Officer | ARQT Arcutis Biotherapeutics, Inc. | 1,320 | $33.7K | — | Feb 2, 2026 | Form 4 ↗ 2 days later · 1,320 shares | Form 144 ↗ |
| Feb 2, 2026 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 3,675 | $93.7K | — | Feb 2, 2026 | Form 4 ↗ 2 days later · 13,469 shares | Form 144 ↗ |
| Feb 2, 2026 | Todd Frank Watanabe officer | ARQT Arcutis Biotherapeutics, Inc. | 19,833 | $505.7K | — | Feb 2, 2026 | Form 4 ↗ 2 days later · 19,833 shares | Form 144 ↗ |
| Feb 2, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 10,000 | $250.5K | 10b5-1 | Feb 2, 2026 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Jan 5, 2026 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 2,490 | $72.2K | 10b5-1 | Jan 5, 2026 | Form 4 ↗ 2 days later · 2,490 shares | Form 144 ↗ |
| Jan 2, 2026 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 10,000 | $289.6K | 10b5-1 | Jan 2, 2026 | Form 4 ↗ 4 days later · 10,000 shares | Form 144 ↗ |
| Dec 31, 2025 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 1,697 | $49.6K | — | Dec 31, 2025 | Form 4 ↗ 2 days later · 1,697 shares | Form 144 ↗ |
| Dec 15, 2025 | Patrick Burnett Officer | ARQT Arcutis Biotherapeutics, Inc. | 11,500 | $332.9K | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 2 days later · 11,500 shares | Form 144 ↗ |
| Dec 1, 2025 | Howard Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | 10,000 | $302.1K | 10b5-1 | Dec 1, 2025 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Dec 1, 2025 | Masaru Matsuda Officer | ARQT Arcutis Biotherapeutics, Inc. | 1,657 | $50.1K | 10b5-1 | Dec 1, 2025 | Form 4 ↗ 2 days later · 1,657 shares | Form 144 ↗ |
| Nov 24, 2025 | Sue-Jean Lin Director | ARQT Arcutis Biotherapeutics, Inc. | 25,272 | $778.0K | — | Nov 24, 2025 | Form 4 ↗ 1 day later · 25,272 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:04 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances